We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Category:Bio Products > Sera and Vaccines Product Name:Group ACYW135 Meningococcal Polysachride CAS No.:1 Standard:ChP Price(USD):Negotiable Company:Hualan Biological Vaccine Inc.
Factory Location: Xinxiang City, Henan Province, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: T/T
【Composition and characteristics】 This product is prepared by extracting and purifying the polysaccharide antigens of Neisseria meningitidis group A, group C, group Y and group W135 from the culture solutions of Neisseria meningitidis group A, group C, group Y and group W135, respectively, mixing, adding appropriate stabilizer and freeze drying. It is a white loose body, which is colorless and clear liquid after redissolving with the attached diluent.
Active ingredients: capsular polysaccharide of Neisseria meningitidis group A, C, Y and W135.
【 Function and use 】
This product is used to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, group C, group Y and group W135.
【 Strength】
0.5ml per bottle after reconstitution according to the marked amount, and 0.5ml for human use every time, containing 50µg of polysaccharides in group A, group C, group Y and group W135.
Three years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
